Not many biotechs survive beyond 25 years, let alone get multiple drugs approved and turn a profit. BioMarin Pharmaceutical has done all that, but finds itself navigating ...

BioMarin Pharmaceutical has made a couple of appointments aimed at boosting its pipeline, both internally and externally, with C-suite appointments in charge of R&D and business development.

Cytokinetics has been a top biotech takeover candidate for some time, thanks to blockbuster speculation about its lead drug aficamten, but a $1 billion-plus set of financing deals shows it is ...

RBC Capital Mkts has recently initiated Cytokinetics, Inc. (CYTK) stock to Outperform rating, as announced on November 8, 2024, according to Finviz. Earlier, on August 13, 2024, Goldman had reduced ...

Edgewise Therapeutics (NASDAQ: EWTX) is a small-cap pharmaceutical stock that has been all the rage recently. Shares are up 55% in the last three months and up 332% over the past 52 weeks.

After hours: January 17 at 6:11:16 PM EST ...

He acted in James McConnel and Kit Hesketh-Harvey's musical, "Orlando," at the Guildhall School of Music and Drama in London, England with Jason Smith, Susanna Day, Julie Gossage, Conleth Hill, and ...

Aficamten is under clinical development by Cytokinetics and currently in Pre-Registration for Hypertrophic Cardiomyopathy. According to GlobalData, Pre-Registration drugs for Hypertrophic ...